The Journal of Organic Chemistry
Article
procedures for THPO formation. Purification by column chromatog-
raphy (10% EtOAc/hexanes) of the crude residue afforded THPO 55
as a clear colorless oil in a 8.3:1.0 cis:trans ratio (16 mg, 40%): Rf =
154.3, 153.2, 132.8, 127.9, 116.1, 114.7, 81.5, 77.0, 70.0, 55.9, 48.0,
46.5, 36.2, 23.0, 20.6, 14.5, 9.3; IR (thin film) 3000, 2960, 2932, 2873,
2852, 1716, 1508 cm−1; HRMS (ES/MeOH) m/z calcd for
C20H28O4Na [M + Na]+ 355.1885, found 355.1884.
1
0.43 (10% EtOAc/hexanes); H NMR (500 MHz, CDCl3) δ 7.42−
7.40 (m, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.28−7.25 (m, 1H), 6.64 (d, J =
15.9 Hz, 1H), 6.23 (dd, J = 15.9, 7.4 Hz, 1H), 3.83 (dd, J = 10.0, 7.6
Hz, 1H), 3.71−3.66 (m, 1H), 2.49−2.37 (m, 3H), 1.75−1.72 (m 1H),
1.59−1.54 (m, 1H), 1.46−1.32 (m, 4H), 1.01 (d, J = 6.7 Hz, 3H), 0.91
(t, J = 3H); 13C NMR (126 MHz, CDCl3) δ 208.5, 136.4, 133.5, 128.7,
128.2, 127.7, 126.8, 84.4, 76.9, 50.3, 48.2, 36.3, 27.5, 22.7, 14.1, 9.6; IR
(thin film) 3026, 2957, 2932, 2860, 1715 cm−1; HRMS (ES/MeOH)
m/z calcd for C18H25O2 [M + H]+ 273.1855, found 273.1857.
(2S,3S,6R)-6-Butyl-3-methyl-2-((E)-prop-1-enyl)dihydro-2H-
pyran-4(3H)-one (56c). Alcohol 25 (69 mg, 0.25 mmol) and
crotonaldehyde (26 mg, 0.37 mmol) were converted to 56c following
the general procedures for THPO formation. Purification by column
chromatography (10% EtOAc/hexanes) of the crude residue afforded
THPO 56 as a clear colorless oil in a 7.0:1.0 cis:trans ratio (16 mg,
30%): Rf = 0.51 (10% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 5.75 (dq, J = 17.4, 6.5 Hz, 1H), 5.51 (app. dqd, J = 15.2, 7.8, 1.8 Hz,
1H), 3.63−3.58 (m, 2H), 2.41 (dd, J = 13.6, 2.4 Hz, 1H), 2.37−2.28
(m, 2H), 1.74 (dd, J = 6.5, 1.6 Hz, 3H), 1.73−1.66 (m, 1H), 1.56−
1.49 (m, 1H), 1.44−1.37 (m, 1H), 1.36−1.28 (m, 3H), 0.93 (d, J = 6.7
Hz, 3H), 0.90 (t, J = 7.0 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ
209.0, 130.6, 130.0, 84.5, 77.6, 50.1, 48.2, 36.3, 27.5, 22.7, 18.0, 14.1,
9.6; IR (thin film) 2959, 2934, 2860, 1717 cm−1; HRMS (ES/MeOH)
m/z calcd for C13H26O2N [M + NH4]+ 228.1964, found 228.1964.
Ethyl 2-((2S,5S,6S)-5-Methyl-4-oxo-6-((E)-prop-1-enyl)tetra-
hydro-2H-pyran-2-yl)acetate (57c). Alcohol 26 (46 mg, 0.15
mmol) and crotonaldehyde (16 mg, 0.23 mmol) were converted to
57c following the general procedures for THPO formation. TMSOTf
was used as the Lewis acid instead of BF3·OEt2. Purification by column
chromatography (20% EtOAc/hexanes) of the crude residue afforded
THPO 57 as a clear colorless oil in a 5.6:1.0 cis:trans ratio (18 mg,
49%): Rf = 0.45 (10% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 5.78−5.68 (m, 1H), 5.48 (app. ddq, J = 14.8, 7.3, 1.8 Hz, 1H), 4.17−
4.06 (m, 3H), 3.66 (dd, J = 10.2, 7.8 Hz, 1H), 2.72 (dd, J = 15.4, 6.8
Hz, 1H), 2.53−2.48 (m, 2H), 2.42 (dd, J = 11.6, 1.1 Hz, 1H), 2.33−
2.26 (m, 1H), 1.73 (dd, J = 6.5, 1.6 Hz, 3H), 1.25 (t, J = 7.2 Hz, 3H),
0.94 (d, J = 6.7 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 207.5, 170.2,
131.0, 129.6, 84.3, 73.6, 60.9, 49.8, 47.4, 41.4, 17.9, 14.3, 9.6; IR (thin
film) 2977, 2935, 2877, 1736, 1717 cm−1; HRMS (ES/MeOH) m/z
calcd for C13H20O4Na [M + Na]+ 263.1259, found 263.1258.
(2S,3S,6S)-6-(Furan-2-yl)-3-methyl-3-phenyl-2-((E)-prop-1-
enyl)dihydro-2H-pyran-4(3H)-one (59c). Alcohol 28 (58 mg, 0.16
mmol) and crotonaldehyde (17 mg, 0.24 mmol) were converted to
59c following the general procedures for THPO formation.
Purification of the crude residue on a preparative TLC plate (10%
EtOAc/hexanes) afforded THPO 59 as a white film in a 6.0:1.0
1
cis:trans ratio (29 mg, 62%): Rf = 0.44 (10% EtOAc/hexanes); H
NMR (500 MHz, CDCl3) δ 7.46 (app. d, J = 1.0 Hz, 1H), 7.37−7.32
(m, 2H), 7.31−7.27 (m, 1H), 7.20−7.18 (m, 2H), 6.40−6.39 (m, 2H),
5.50−5.43 (m, 1H), 5.17 (ddt, J = 15.4, 5.6, 4.9 Hz, 1H), 5.02 (dd, J =
12.4, 3.0 Hz, 1H), 4.59 (d, J = 5.5 Hz, 1H), 3.28 (dd, J = 15.8, 12.4 Hz,
1H), 2.71 (dd, J = 15.8, 3.1 Hz, 1H), 1.62 (s, 3H), 1.53 (dd, J = 6.5,
1.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 209.8, 152.7, 143.1,
139.5, 130.0, 128.4, 128.3, 127.3, 124.8, 110.5, 108.0, 84.4, 72.0, 58.8,
42.0, 18.0, 16.7; IR (thin film) 3031, 2989, 2916, 2854, 1714 cm−1;
HRMS (ES/MeOH) m/z calcd for C19H20O3Na [M + Na]+ 319.1310,
found 319.1305.
6-Butyl-3-methyl-3-phenyl-2-styryldihydro-2H-pyran-4(3H)-
one (60). Alcohol 29 (36 mg, 0.10 mmol) and cinnamaldehyde (20
mg, 0.15 mmol) were converted to 60 following the general
procedures for THPO formation. Purification by column chromatog-
raphy (10% EtOAc/hexanes) of the crude residue afforded THPO 60
as a clear colorless oil in a 8.2:1.0 cis:trans ratio (24 mg, 69%). A small
amount of THPO 60c and THPO 60t was separated for character-
ization, but most of it was recovered as a mixture of the two
diastereomers; Rf = 0.28 (10% EtOAc/hexanes): THPO 60c: 1H
NMR (500 MHz, CDCl3) δ 7.37 (app. t, J = 7.5 Hz, 2H), 7.31−7.17
(m, 8H), 6.46 (dd, J = 16.1, 1.4 Hz, 1H), 5.74 (dd, J = 16.1, 4.4 Hz,
1H), 4.64 (dd, J = 4.4, 1.6 Hz, 1H), 3.99−3.93 (m, 1H), 2.71 (dd, J =
15.6, 11.9 Hz, 1H), 2.52 (dd, J = 15.6, 2.9 Hz, 1H), 1.87−1.81 (m,
1H), 1.69−1.63 (m, 1H), 1.58−1.55 (m, 1H), 1.56 (s, 3H), 1.48−1.37
(m, 3H), 0.96 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ
210.9, 139.6, 136.9, 131.9, 128.6, 128.43, 128.41, 127.7, 127.4, 126.5,
124.4, 83.9, 76.9, 58.7, 44.4, 36.3, 27.6, 22.8, 16.8, 14.2; IR (thin film)
3057, 3026, 2956, 2930, 2859, 1714 cm−1; HRMS (ES/MeOH) m/z
calcd for C24H28O2Na [M + Na]+ 371.1987, found 371.1986. THPO
60t: 1H NMR (500 MHz, CDCl3) δ 7.39−7.37 (m, 6H), 7.33 (app. t, J
= 7.4 Hz, 2H), 7.29−7.26 (m, 2H), 6.76 (d, J = 15.6 Hz, 1H), 6.27
(dd, J = 15.6, 8.4 Hz, 1H), 5.22 (d, J = 8.4 Hz, 1H), 4.16 (quintet, J =
6.5 Hz, 1H), 2.41−2.39 (m, 2H), 1.61−1.53 (m, 1H), 1.46−1.37 (m,
1H), 1.30−1.17 (m, 7H), 0.84 (t, J = 3H); 13C NMR (126 MHz,
CDCl3) δ 210.4, 142.4, 136.4, 136.2, 129.0, 128.8, 128.4, 127.1, 127.0,
126.9, 124.3, 80.7, 72.7, 58.2, 45.1, 35.9, 27.2, 22.7, 22.2, 14.1; IR (thin
film) 3058, 3026, 2956, 2928, 2860, 1711 cm−1; HRMS (ES/MeOH)
m/z calcd for C24H28O2Na [M + Na]+ 371.1987, found 371.1995.
6-Butyl-3-methyl-3-phenyl-2-((E)-prop-1-enyl)dihydro-2H-
pyran-4(3H)-one (61). Alcohol 29 (79 mg, 0.23 mmol) and
crotonaldehyde (30 mg, 0.43 mmol) were converted to 61 following
the general procedures for THPO formation. Purification by column
chromatography (10% EtOAc/hexanes) of the crude residue afforded
THPO 61c (39 mg, 60%) and 61t (14 mg, 22%) as a clear colorless
oil. THPO 61c: Rf = 0.35 (10% EtOAc/hexanes); 1H NMR (500
MHz, CDCl3) δ 7.26 (app. t, J = 7.5 Hz, 1H), 7.20−7.17 (m, 2H),
7.09 (dd, J = 8.3, 1.1 Hz, 2H), 5.44 (dqd, J = 15.4, 6.6, 1.4 Hz, 1H),
5.03 (dd, J = 15.5, 2.2 Hz, 1H), 4.34 (dd, J = 3.7, 1.2 Hz, 1H), 3.81
(ddq, J = 12.6, 6.6, 1.8 Hz, 1H), 2.58 (dd, J = 15.6, 11.9 Hz, 1H), 2.39
(dd, J = 15.5, 2.9 Hz, 1H), 1.73−1.67 (m, 1H), 1.57−1.51 (m, 1H),
1.49 (app. dt, J = 6.6, 1.4 Hz, 3H), 1.46 (s, 3H), 1.44−1.41 (m, 1H),
1.37−1.27 (m, 3H), 0.87 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz,
CDCl3) δ 211.2, 139.8, 129.0, 128.4, 128.2, 127.1, 125.4, 84.0, 76.9,
58.6, 44.4, 36.3, 27.5, 22.8, 18.0, 16.6, 14.2; IR (thin film) 3031, 2957,
2932, 2859, 1714 cm−1; HRMS (ES/MeOH) m/z calcd for
C19H26O2Na [M + Na]+ 309.1830, found 309.1820. THPO 61t: Rf
= 0.35 (10% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.35−
7.32 (m, 4H), 7.25−7.22 (m, 1H), 5.88 (dq, J = 17.2, 5.0 Hz, 1H),
5.60 (ddq, J = 14.9, 8.9, 1.9 Hz, 1H), 5.02 (d, J = 8.9 Hz, 1H), 4.09−
6-((Z)-Hex-3-enyl)-2-((4-methoxyphenoxy)methyl)-3-
methyldihydro-2H-pyran-4(3H)-one (58). Alcohol 27 (46 mg,
0.15 mmol) and 2-(4-methoxyphenoxy)acetaldehyde (38 mg, 0.23
mmol) were converted to 58 following the general procedures for
THPO formation using TMSOTf instead of BF3·OEt2. Purification by
column chromatography (20% EtOAc/hexanes) of the crude residue
afforded THPO 58c (28 mg, 55%) and 58t (8 mg, 17%) as a clear
1
colorless oil: THPO 58c: Rf = 0.42 (20% EtOAc/hexanes); H NMR
(500 MHz, CDCl3) δ 6.83−6.78 (m, 4H), 5.54−5.47 (m, 1H), 5.22
(ddd, J = 15.3, 8.7, 1.5 Hz, 1H), 4.02 (dd, J = 10.4, 2.0 Hz, 1H), 3.85
(dd, J = 10.4, 6.1 Hz, 1H), 3.82−3.77 (m, 1H), 3.76 (s, 3H), 3.42
(ddd, J = 10.2, 6.1, 2.0 Hz, 1H), 2.75 (dd, J = 15.5, 7.3 Hz, 1H), 2.54−
2.40 (m, 3H), 2.19−2.12 (m, 1H), 1.82 (dq, J = 13.2, 3.5 Hz, 1H),
1.69 (dq, J = 12.7, 4.3 Hz, 1H), 1.62 (dd, J = 6.4, 1.5 Hz, 3H), 1.46 (m,
1H), 1.37−1.29 (m, 1H), 1.02 (t, J = 7.3 Hz, 3H); 13C NMR (126
MHz, CDCl3) δ 210.3, 153.9, 153.5, 131.6, 127.2, 116.0, 114.6, 80.2,
74.4, 70.8, 55.8, 49.0, 41.0, 37.2, 31.2, 30.8, 18.2, 7.7; IR (thin film)
2935, 2918, 2876, 2854, 1714, 1508 cm−1; HRMS (ES/MeOH) m/z
calcd for C20H28O4Na [M + Na]+ 355.1885, found 355.1878. THPO
58t: Rf = 0.53 (20% EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ
6.91−6.89 (m, 2H), 6.84−82 (m, 2H), 5.42−5.37 (m, 1H), 5.31−5.26
(m, 1H), 4.22 (ddd, J = 10.6, 2.0 Hz, 1H), 4.06 (ddd, J = 10.6, 4.4 Hz,
1H), 3.77 (s, 3H), 3.66−3.61 (m, 1H), 3.53 (ddd, J = 10.5, 4.3, 2.0 Hz,
1H), 2.78−2.72 (m, 1H), 2.50−2.36 (m, 2H), 2.22 (app. sextet, J = 7.7
Hz, 1H), 2.14 (app. sextet, J = 7.2 Hz, 1H), 2.06 (quintet, J = 7.8 Hz,
2H), 1.84−1.76 (m, 1H), 1.56−1.50 (m, 1H), 1.05 (d, J = 6.6 Hz,
3H), 0.95 (t, J = 7.5 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 208.8,
8746
dx.doi.org/10.1021/jo501580p | J. Org. Chem. 2014, 79, 8733−8749